Skip to main content

Correction to: Mesenchymal stem cells in the treatment of severe COVID-19

The Original Article was published on 09 August 2021


Correction to: Transl Med Commun 6, 16 (2021)

Following publication of the original article [1], the authors reported an error in the list of affiliations and requested to remove affiliation 2 “University of California San Diego Health System, Translational Neurosciences and Neurotherapeutics, Santa Monica, CA 90404, USA.”

The original article [1] has been updated.


  1. Kesari S, Kasper GC, Verkh L, et al. Mesenchymal stem cells in the treatment of severe COVID-19. Transl Med Commun. 2021;6:16.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Santosh Kesari or Gregory C. Kasper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kesari, S., Kasper, G.C., Verkh, L. et al. Correction to: Mesenchymal stem cells in the treatment of severe COVID-19. transl med commun 6, 19 (2021).

Download citation

  • Published:

  • DOI: